Trials / Unknown
UnknownNCT02391168
Fatty Liver Disease Collaborative Research in China
A Multi-center, Prospective Cohort Study on the Natural History of Fatty Liver Disease in China
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Fatty Liver and Alcoholic Liver Disease Study Group, China · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A multi-center, prospective cohort study on the natural history of fatty liver disease in China
Detailed description
This is a multicenter, prospective and open-enrollment epidemiologic study. All the patients with liver biopsy-proven macrovesicular steatosis (\>5%) will be enrolled in the baseline cross-sectional analysis. Those who are either diagnosed as NAFLD or ALD, if meeting all the inclusion and exclusion criteria, will be enrolled in the following cohort study, will be followed up after 1 year, 3 years and 5 years with a visit window of +1 month.
Conditions
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2015-03-18
- Last updated
- 2015-08-05
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02391168. Inclusion in this directory is not an endorsement.